UNSPSC 85581604: Revision of autologous tissue substitute in mouth and throat, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in mouth and throat, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CWY37Z

UNSPSC 85581604, Revision of autologous tissue substitute in mouth and throat, percutaneous approach, is a Commodity code showing minimal alignment with recent state and local procurement activity. The code nominally describes a surgical procedure involving tissue repair in the oral cavity, but the recent opportunities posted under this code reflect administrative healthcare services, pharmacy benefit management, occupational medical surveillance, and staffing procurement—none of which involve the procedure or the clinical specialization the code describes.

The City of Phoenix Retirement Office, the City of Long Beach, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System have posted opportunities tagged to this code since mid-August 2026. The work ranges from independent disability medical evaluation services (City of Phoenix, RFP RTMRFP26001, due October 16, 2026) to surgical benefit carve-out network management (City of Long Beach, RFP HR26753, due October 7, 2026) to occupational health surveillance (Washington State Ferries, RFP RFP20260825, due October 9, 2026) to pharmacy benefit management (Collier County, RFP 25-8414, due April 9, 2026). The geographic spread spans Arizona, California (Long Beach and Santa Clara County), Washington, Texas (Harris County), and Florida (Collier County). The code appears to be a miscategorization by issuing bodies; the recent opportunities bear no material relationship to autologous tissue-substitute revision procedures, and a business development professional evaluating this code for procedural work would find no relevant recent activity to pursue.